CEACAM5 and colorectal carcinoma: Through data analysis from 223 CRC patients and 130 healthy controls [77], the sensitivity of miR-24, miR-320a and miR-423-5p for early stage CRC were 77.78%, 90.74% and 88.89%, which were better than CEA and CA19-9 (40.54% and 36.04%, respectively).